Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SQLE | Q14534 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923284 | 0.96 | S1PR4 (0.36) | S1PR4S1PR1S1PR3ALDH1A1RAB9A | |
| SCHEMBL917789 | 0.91 | APP (0.39) | S1PR4S1PR1S1PR3ALDH1A1GNAI3 | |
| SCHEMBL21518353 | 0.87 | APP (0.39) | S1PR4S1PR1S1PR3ALDH1A1GNAI3 | |
| SCHEMBL11807435 | 0.85 | S1PR4 (0.43) | S1PR4S1PR1S1PR3ALDH1A1RAB9A | |
| SCHEMBL918238 | 0.83 | S1PR4 (0.41) | S1PR4S1PR1S1PR3ALDH1A1GNAI3 | |
| SCHEMBL918520 | 0.83 | CXCR4 (0.44) | S1PR4S1PR1S1PR3ALDH1A1KDM4E | |
| SCHEMBL11516269 | 0.82 | APP (0.38) | S1PR4S1PR1S1PR3GNAI3GNAO1 | |
| SCHEMBL37872 | 0.81 | CXCR4 (0.46) | ALDH1A1KDM4EEPHX1CA12CXCR4 | |
| SCHEMBL21518374 | 0.81 | CXCR4 (0.46) | ALDH1A1KDM4EEPHX1CA12CXCR4 | |
| SCHEMBL918578 | 0.81 | CXCR4 (0.46) | ALDH1A1KDM4EEPHX1CA12CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4190832-B1 | POLYISOCYANATE COMPOSITION, COATING COMPOSITION AND COATED SUBSTRATE | ASAHI CHEMICAL IND (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2026-02-24 | — | — | US | disclosed |
| EP-4144780-B1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| EP-3878838-B1 | POLYISOCYANATE COMPOSITION, COATING COMPOSITION AND COATED SUBSTRATE | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-120059105-A | Polyisocyanate composition, coating composition and coated substrate | 旭化成株式会社 | 2025-05-30 | — | — | CN | disclosed |
| EP-4332137-A1 | BASE COATING COMPOSITION, MULTILAYER COATING FILM LAMINATE, AND METHOD FOR FORMING MULTILAYER COATING FILM LAMINATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117645828-A | Coating composition for substrate, multilayer coating film laminate, and method for forming multilayer coating film laminate | 旭化成株式会社 | 2024-03-05 | — | — | CN | disclosed |
| CN-117264175-A | Polyisocyanate composition, aqueous coating composition, coated substrate, and method for producing polyisocyanate composition | 旭化成株式会社 | 2023-12-22 | — | — | CN | disclosed |
| EP-4293060-A1 | POLYISOCYANATE COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN COMPOSITION, COATING COMPOSITION AND COATING SUBSTRATE | Asahi Kasei Kabushiki Kaisha (JP) | 2023-12-20 | — | — | EP | disclosed |
| CN-117229476-A | Polyisocyanate composition, blocked polyisocyanate composition, polyurethane resin composition, coating composition, and coated substrate | 旭化成株式会社 | 2023-12-15 | — | — | CN | disclosed |
| US-7253306-B2 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-07 | — | — | US | disclosed |
| US-7253306-B2 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-07 | — | — | US | disclosed |
| US-7253306-B2 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-07 | — | — | US | disclosed |
| US-20070010573-A1 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2007-01-11 | — | — | US | disclosed |
| US-20070010573-A1 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2007-01-11 | — | — | US | disclosed |
| US-20070010573-A1 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2007-01-11 | — | — | US | disclosed |
| EP-1644325-A2 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | Neurochem (International) Limited (CH) | 2006-04-12 | — | — | EP | disclosed |
| US-20050143462-A1 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-06-30 | — | — | US | disclosed |
| US-20050096385-A1 | Methods and compositions for treating amyloid-related diseases | BHI LIMITED PARTNERSHIP (CA) | 2005-05-05 | — | — | US | disclosed |
| WO-2004113275-A2 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | TMT1A, SRMS, FTO | S1PR4 4179/4885S1PR1 4135/4885S1PR3 4467/4885 |
| US-20050143462-A1 | Pharmaceutical drug candidates and methods for preparation thereof | MPST, TTR, STS | S1PR4 1075/4885S1PR1 393/4885S1PR3 418/4885 |
| US-20050096385-A1 | Methods and compositions for treating amyloid-related diseases | APP, PSEN1, PSEN2 | S1PR4 3981/4885S1PR1 3406/4885S1PR3 3633/4885 |
| US-20070010573-A1 | Methods and compositions for treating amyloid-related diseases | APP, PSEN1, PSEN2 | S1PR4 3981/4885S1PR1 3406/4885S1PR3 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.